Neonatal Dose Individualization
Neonatal Dose Individualization is a clinical pharmacological approach that tailors drug dosage regimens to individual newborns based on physiological, genetic, and developmental factors unique to the neonatal period, thereby optimizing therapeutic efficacy and minimizing toxicity.
5
Publications
127
Citations
44
Authors
34
Institutions
Publications per year
2017–2026
2
Parents
5
J H von Heppe, Heiko Krude, Dagmar l’Allemand et al. · Journal of Pediatric Endocrinology and Metabolism · 2004 · 30 citations
Medicine, Endocrinology, Pediatrics +15
Qian Dong, Stéphanie Leroux, Haiyan Shi et al. · Antimicrobial Agents and Chemotherapy · 2018 · 22 citations · Full text
Patrick J. McNamara, David E. Burgio, Sun Dong Yoo · Toxicology and Applied Pharmacology · 1991 · 20 citations
1–5 of 5
44
2
h-index
2
h-index
2
h-index
1
h-index
1
h-index
1–5 of 44
34
Shandong University
Jinan, China
2 h-index
12 publications
327 citations
Inserm
Paris, France
2 h-index
2 publications
55 citations
Assistance Publique – Hôpitaux de Paris
Paris, France
2 h-index
2 publications
53 citations
Hôpital Robert-Debré
Paris, France
2 h-index
3 publications
84 citations
Centre Hospitalier Universitaire de Rennes
Rennes, France
2 h-index
2 publications
53 citations
University of Southern California
Los Angeles, United States
1 h-index
1 publications
24 citations

Children's National
Washington, United States
1 h-index
1 publications
31 citations
University of Kentucky
Lexington, United States
1 h-index
2 publications
40 citations
1–8 of 34
1 publications · 24 citations
1
h-index
1 publications · 30 citations
1
h-index
TAAP · 1 publications · 20 citations
1
h-index
AAC · 1 publications · 22 citations
1
h-index
1 publications · 31 citations
1
h-index
1–5